The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma.
D000818:Animals; D001374:Azacitidine / Q000494:pharmacology*; D002460:Cell Line; D002999:Clone Cells / Q000378:metabolism; D007376:Interleukin-2 / Q000096:biosynthesis* / Q000502:physiology; D008213:Lymphocyte Activation; D051379:Mice; D051381:Rats; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D013945:Thymoma / Q000276:immunology / Q000378:metabolism*
D007376:Interleukin-2; D001374:Azacitidine